D6014C00007: An Open-label, Non-randomised, Multicentre Study to Allow Continued Access to and Assess the Safety and Tolerability of AZD1775 for Patients Enrolled in AZD1775 Clinical Pharmacology Studies

February 24, 2019
Cancer - Ovarian, Solid Tumors, Cancer - Lung
Principal Investigator: Ding Wang, MD
Cancer, Phase I, Phase 1, Solid Tumors, AZD1775, Lung, NSCLC, Ancillary